Advertisement

Gastroenterology

Home Gastroenterology
Screening with flexible sigmoidoscopy reduces all-cause mortality

Flexible Sigmoidoscopy Screening Reduces Mortality

Reduction in all-cause mortality at 11 to 12 years using data from individual NORCCAP study cohorts
For women

Hours Worked Impacted by Kids for Female, Not Male Doctors

Findings from a national sample of dual-physician couples
Most patients with ulcerative colitis do not achieve the 'Treat to Target' end point of composite clinical and endoscopic remission

Most Ulcerative Colitis Patients Do Not Achieve Target Remission

Thirty-five percent of patients in real-world care met target of clinical and endoscopic remission
Higher dietary energy density (the ratio of energy intake to food weight) is associated with increased risk of obesity-related cancers among normal-weight women

Dietary Energy Density May Up Risk of Obesity-Linked Cancers

DED linked to 10 percent increase of any obesity-related cancer among normal-weight women
In non-alcoholic fatty liver disease

Plasma Amino Acids Up in Non-Alcoholic Fatty Liver Disease

Ballooning/inflammation at liver biopsy linked to increased plasma branched chain, aromatic AAs
The U.S. Food and Drug Administration has announced a recall of numerous liquid pharmaceutical products because of possible bacterial contamination that could cause severe infections in vulnerable patients.

FDA: Potential Contamination in Some Liquid Pharma Products

Concerns over possible bacterial contamination that could cause severe infections in vulnerable patients
Fecal calprotectin adds most to discrimination between pediatric patients with and without inflammatory bowel disease

Fecal Calprotectin Is Best Marker for Discriminating Pediatric IBD

Blood markers, fecal calprotectin aid discrimination between pediatric patients with, without IBD
Adoption of specialty access standards has not improved access to specialists

Specialist Access No Better With Adoption of Access Standards

No notable improvement in timely access to specialty services following implementation of standards
Many studies used to support U.S. Food and Drug Administration approval of high-risk medical device modifications are not controlled; and efficacy of drugs granted accelerated approval is often confirmed three years after approval

Studies Used for FDA Approval of Device Changes Often Low Quality

And, efficacy of drugs granted accelerated approval often confirmed only years after approval
Two doses of killed whole-cell oral cholera vaccine are efficacious for protecting against cholera for at least two years after vaccination

Review: Killed Whole-Cell Oral Cholera Vaccine Efficacious

Efficacy estimates similar during the two years after vaccination; efficacy reduced in third, fourth year